Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Local ropivacaine infiltration for postoperative pain after Kocher's incision
IRCT20250731066712N1Phase 3Completed
- Sponsor
- Alborz University of Medical Sciences
- Start
- Aug 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ropivacaine in postoperative pain (2 arms), sponsored by Alborz University of Medical Sciences. Primary endpoints: Postoperative pain score by VAS, Time to first rescue analgesic administration and 1 more. Started Aug 2025; status: completed.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on IRCT20250731066712N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250731066712N1.